Etiam fringilla turpis at eros fermentum, a tincidunt sapien commodo. Integer egestas imperdiet eros vitae rutrum. Quisque iaculis ullamcorper fermentum. Maecenas tortor tortor, euismod vitae felis eget, condimentum scelerisque ante. Nullam vitae ipsum enim. Integer at suscipit nunc, ut ornare purus. Curabitur ut enim id massa aliquam tristique. Donec non lacinia dui, eu volutpat erat. Sed quis urna est. Vivamus vestibulum felis id neque porta vestibulum. In congue dui est, vitae semper odio feugiat lacinia. Sed vitae bibendum metus, id convallis metus.
- Etiam ut quam vitae dolor tristique maximus ut ut nisl.
- Nam ac leo id lorem sollicitudin suscipit ac vel ante.
- Phasellus nec lorem non erat posuere consequat.
- Duis in dui ac nibh eleifend efficitur.
- Donec sit amet nulla bibendum tortor ornare suscipit.
- Donec efficitur risus at diam sagittis ornare.
- Suspendisse accumsan turpis vitae enim tincidunt, sed sagittis urna molestie.
- Nunc venenatis metus vitae sodales tempor.
- Nunc bibendum diam eu quam commodo euismod.
- Integer tristique lorem feugiat urna fermentum iaculis.
- In imperdiet nulla eu sagittis bibendum.
Nam at arcu nibh. Pellentesque diam tortor, venenatis eget congue et, vestibulum id ante. Suspendisse maximus justo eget nulla tristique eleifend. Suspendisse eu tempor nulla. Nam purus massa, maximus ac varius a, iaculis ut sapien. Nunc tincidunt nisi nec vestibulum gravida. Fusce hendrerit felis eu volutpat bibendum. Donec consequat, mi et eleifend pulvinar, nibh purus cursus ex, eget aliquet libero tortor id nulla. Sed dignissim arcu consectetur dui congue, ut hendrerit enim vulputate. Vestibulum placerat nibh purus, vel consequat nibh blandit vel. Nullam consectetur, dolor id pulvinar ultrices, odio dolor accumsan neque, in sollicitudin erat orci a arcu. Nam vestibulum, nulla in suscipit sagittis, justo dui finibus est, ac egestas purus turpis in ipsum. Curabitur rutrum egestas eros, ac viverra eros egestas in.
San Francisco, CA – 2023 Genitourinary Symposium – Chair Dr. Christian Kollmannsberger gives the Welcome of the Day during Opening session at the 2023 Genitourinary Cancers Symposium, Thursday February 16, 2023. Photo by © ASCO/Todd Buchanan 2023
BSc, MD FRCPC
Clinical Assistant Professor of Medicine
BC Cancer – Vancouver
Dr. Jiti Gill is a medical oncologist at BC Cancer with a clinical practice specializing in gastrointestinal malignancies. She completed her medical degree and internal medicine training at Western University, followed by a hematology residency at McMaster University and a medical oncology residency at University of British Columbia.
BSc, MD FRCPC, MPH, MBA
Professor of Medicine
BC Cancer – Vancouver
Medical Oncologist, Vancouver Cancer Centre
Professor, Faculty of Medicine, University of British Columbia
Dr. Sharlene Gill is a Professor of Medicine at the University of British Columbia and a medical oncologist specializing in GI malignancies at BC Cancer – Vancouver. She received a BSc Pharmacy and an MD from the University of British Columbia in 1996 followed by residencies in Internal Medicine and Medical Oncology. Dr. Gill subsequently completed a fellowship in Gl Oncology at the Mayo Clinic (Rochester, MN) and a Masters of Public Health from the Harvard School of Public Health (Boston, MA). In 2017, she completed an MBA from the Kenan-Flagler School of Business at the University of North Carolina. She is actively engaged in education and research, with over 120 peer-reviewed publications and book chapters to her credit. Dr. Gill serves as the Chair of the Canadian Clinical Trials Group (CCTG) GI Disease Site Committee, Chair of the UBC Department of Medicine Mentoring Committee and Chair of the BC Cancer Medical Advisory Committee. She is the President of the Canadian Association of Medical Oncologists (2022-2024). Her TEDx talk in 2022 on ‘How to Flip the Script on Cancer’ delivered her passion for patient advocacy and empowerment.
MD FRCPC, MPH
Assistant Professor of Medicine
BC Cancer – Vancouver
Hematologist, Centre for Lymphoid Cancer, BC Cancer
Dr. Alina Gerrie is a hematologist and Assistant Professor in the Divisions of Medical Oncology and Hematology at the University of British Columbia (UBC) and a Clinician Investigator at the Centre for Lymphoid Cancer at BC Cancer, Vancouver Centre. She completed her medical degree and internal medicine residency at the University of Toronto, followed by hematology residency at UBC. She undertook a fellowship through the Royal College Clinical Investigator Program and earned a Master’s of Public Health degree from Harvard University, where her research included investigating the impact of genetic abnormalities on population-level outcomes in chronic lymphocytic leukemia (CLL) patients. Dr. Gerrie currently holds a Michael Smith Health Research Investigator Award and is involved in translational, clinical trial and outcomes-based research related to leukemia and lymphoma. Other academic interests include the investigation of novel therapeutics and cellular therapy for CLL and lymphoma.
MD FRCPC
Professor of Medicine
BC Cancer – Vancouver
Medical Oncologist, Vancouver Cancer Centre and Vancouver Prostate Centre
Chief Medical Officer, BC Cancer
Professor, Faculty of Health Sciences, Simon Fraser University
Shrum Chair in Prostate Cancer Research
Dr. Chi is a medical oncologist and the Chief Medical Officer of BC Cancer, which provides a comprehensive cancer control program for the people of British Columbia (BC), in Canada. He is also a Professor in the Faculty of Medicine at the University of British Columbia, a Professor in the Faculty of Health Sciences at Simon Fraser University, and the Shrum Chair in Prostate Cancer Research at BC Cancer.
Dr. Chi’s research in the field of genitourinary cancers focuses on prostate cancer and investigational new drugs, where he has contributed to changing international standards of care practice for patients with advanced prostate cancer. He also has been investigating circulating tumour DNA as a source of prognostic and predictive biomarkers for patients with metastatic prostate cancer. Dr. Chi is the past-Chair of the Genitourinary Disease and Investigational New Drugs Site Committees with the Canadian Cancer Trials Group, and has held peer-reviewed grant funding from the Canada Institutes of Health Research (CIHR), National Cancer Institute of Canada (NCIC)/Canadian Cancer Society (CCS), the US Department of Defence, Movember, Prostate Cancer Foundation (USA), and Prostate Cancer Canada.
Dr. Chi is an author on over 280 articles in peer-reviewed journals including the Journal of Clinical Oncology, Annals of Oncology, Lancet Oncology, Cancer Discovery, Nature, and the New England Journal of Medicine.
BMSc, MS, MD FRCPC
Associate Professor of Medicine
BC Cancer – Vancouver
CCTG Colon Cancer Disease Oriented Group Co-Chair
CCTG Senior Investigator
US NCI Colon Cancer Task Force Co-Chair
NANETs Guidelines Committee Co-Chair
COMMNETs Translational Research Group Co-Chair
Jonathan Loree is a medical oncologist at BC Cancer and Senior Investigator at CCTG with an interest in GI malignancies. He completed his medical oncology fellowship at BC Cancer and subsequently undertook a translational research fellowship at MD Anderson Cancer Center where he completed a Master’s of Science before returning to British Columbia. His research focus is translational research and biomarker development in colorectal cancer and neuroendocrine neoplasms.
